DUBLIN--(BUSINESS WIRE)--The 'India Cancer Diagnostics Test Market: Test Price By Indication & Future Outlook 2028' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“印度癌症诊断测试市场：2028年适应症测试价格和未来展望”报告已添加到ResearchAndMarkets.com的产品中。

The cancer diagnostic market in India is a collaborative effort involving both government and private players. Government institutions like the All India Institute of Medical Sciences (AIIMS) and the Tata Memorial Centre are pivotal in research, diagnosis and treatment, serving patients from various socioeconomic backgrounds.

印度的癌症诊断市场是政府和私人参与者共同努力的结果。像全印度医学科学研究所（AIIMS）和塔塔纪念中心这样的政府机构在研究、诊断和治疗方面至关重要，为来自不同社会经济背景的患者提供服务。

In the private sector, major hospital chains such as Apollo Hospitals, Max Healthcare and Fortis Healthcare are key players, alongside specialized diagnostic companies like Metropolis Healthcare, Dr Lal PathLabs and Vijaya Diagnostic Centre..

在私营部门，阿波罗医院、Max Healthcare和Fortis Healthcare等大型连锁医院以及Metropolis Healthcare、Lal PathLabs博士和Vijaya诊断中心等专业诊断公司是关键参与者。。

Additionally, international companies like Siemens Healthineers, GE Healthcare and Philips Healthcare contribute advanced technologies and expertise to the Indian market. The burgeoning market has also witnessed the emergence of various startups across India such as OncoStem Diagnostics and PredOmix, which are bringing next generation expertise and tools in cancer diagnosis..

此外，西门子Healthineers、GE Healthcare和飞利浦Healthcare等国际公司为印度市场提供了先进的技术和专业知识。新兴市场还见证了印度各地各种初创公司的出现，如OncoStem Diagnostics和PredOmix，它们为癌症诊断带来了下一代专业知识和工具。。

India Cancer Diagnostics Test Market, Test Price By Indication & Future Outlook 2028 Report Offering:

India Cancer Diagnostic Tests Market Opportunity: > US$ 250 Million

印度癌症诊断测试市场机会：>2.5亿美元

India Cancer Diagnostic Tests Market Current & Future Scenario

印度癌症诊断测试市场现状和未来情景

Cancer Diagnostic Tests Market Business Models In India

印度癌症诊断测试市场商业模式

India Cancer Diagnostic Tests Market Size (2024 -2028) By Indications

印度癌症诊断测试市场规模（2024-2028年）

Cancer Diagnostic Tests Availability & Pricing By Indications, Labs/Hospitals & City

癌症诊断测试的可用性和定价（按适应症、实验室/医院和城市）

Multiple Antigen Test Costs By Indications, Market & Labs/Hospitals

适应症，市场和实验室/医院的多种抗原检测成本

Estimated Cancer Cases (2024 -2028) By Indication

根据适应症估计的癌症病例（2024-2028）

The need for cancer diagnostic tests in India is both significant and urgent. With a population exceeding 1.4 Billion, the country faces unique challenges in providing comprehensive cancer care. Many cases are diagnosed at late stages due to a combination of factors including lack of awareness, limited access to healthcare facilities and financial constraints.

印度对癌症诊断测试的需求既重要又紧迫。该国人口超过14亿，在提供全面的癌症护理方面面临着独特的挑战。许多病例是在晚期诊断出来的，这是由于多种因素的综合作用，包括缺乏意识，获得医疗保健设施的机会有限以及资金限制。

Improved availability and accessibility of diagnostic tests could lead to earlier detection and, consequently, better treatment outcomes for patients across the country..

提高诊断测试的可用性和可及性可能会导致更早的检测，从而为全国患者提供更好的治疗结果。。

India's cancer diagnostic tests market is experiencing rapid growth, driven by the rising incidence of cancer in the country and increasing awareness about the importance of early detection. Cancer has become a major public health concern in India, with over 1 Million new cases diagnosed annually and around 900,000 deaths per year.

印度的癌症诊断测试市场正在经历快速增长，这是由于该国癌症发病率的上升以及人们对早期发现重要性的认识不断提高。癌症已成为印度主要的公共卫生问题，每年诊断出100多万例新病例，每年约有90万人死亡。

This situation underscores the critical need for effective and accessible diagnostic tests across the nation..

这种情况强调了在全国范围内对有效且可访问的诊断测试的迫切需求。。

Among the most prominent cancers in India are breast cancer, oral cancer, cervical cancer, lung cancer, colorectal cancer and stomach cancer. Each of these cancer types requires specific diagnostic test approaches, contributing to the complexity of the cancer diagnostic landscape in India.

印度最突出的癌症包括乳腺癌、口腔癌、宫颈癌、肺癌、结直肠癌和胃癌。这些癌症类型中的每一种都需要特定的诊断测试方法，这加剧了印度癌症诊断领域的复杂性。

A wide range of diagnostic tests are available for these cancers, including imaging tests such as X-rays, CT scans, MRI scans, PET scans and ultrasounds. Endoscopy procedures like colonoscopy, bronchoscopy and upper endoscopy are also commonly used. Biopsy methods, including fine-needle aspiration, core needle biopsy, and surgical biopsy, play crucial role in definitive diagnosis.

这些癌症有多种诊断测试，包括X射线、CT扫描、MRI扫描、PET扫描和超声波等成像测试。内镜检查程序如结肠镜检查，支气管镜检查和上内镜检查也很常用。活检方法，包括细针穿刺，核心穿刺活检和手术活检，在明确诊断中起着至关重要的作用。

Blood tests, such as complete blood count, tumor marker tests, and circulating tumor cell tests, are often employed for screening and monitoring. Additionally, specific tests like Pap smears and HPV tests for cervical cancer, and mammography for breast cancer screening, are essential components of cancer diagnostics in India..

血液检测，如全血细胞计数、肿瘤标志物检测和循环肿瘤细胞检测，通常用于筛查和监测。此外，宫颈癌的巴氏涂片和HPV检测以及乳腺癌筛查的乳房X光检查等特定检测是印度癌症诊断的重要组成部分。。

Along with these, domestic academic institutions and research organizations have also been key driving forces behind the tremendous innovation and development observed in the Indian cancer diagnostic tests market. The International Institute of Information Technology (IIIT), Hyderabad is one noteworthy example; in 2023, the institute announced the development of a screening tool for oral cancer.

除此之外，国内学术机构和研究组织也是印度癌症诊断测试市场巨大创新和发展背后的关键驱动力。海得拉巴国际信息技术研究所（IIIT）是一个值得注意的例子；2023年，该研究所宣布开发口腔癌筛查工具。

The tool was created in collaboration between iHub-Data at IIIT-H and INAI, an applied AI research center managed by IIIT-H, the Telangana government, Intel, and the Public Health Foundation of India..

该工具是由IIIT-H的iHub数据与IIIT-H管理的应用人工智能研究中心INAI、特兰加那政府、英特尔和印度公共卫生基金会合作创建的。。

The future of India's cancer diagnostic tests market looks promising for companies seeking entry, with several factors contributing to this positive outlook. This predominantly includes government initiatives like the National Cancer Control Programme and the Ayushman Bharat Scheme, which are increasing focus on cancer prevention, early detection and treatment.

对于寻求进入的公司来说，印度癌症诊断测试市场的未来前景看好，有几个因素促成了这一积极前景。。

Further, for companies looking to enter or expand in India's cancer diagnostic marker, there is a growing emphasis on developing affordable solutions. Given the large population and diverse economic conditions in India, there is a significant opportunity for companies that can provide high quality, cost effective diagnostic tests..

此外，对于希望进入或扩大印度癌症诊断标志的公司来说，越来越重视开发负担得起的解决方案。鉴于印度人口众多，经济状况多样，对于能够提供高质量，成本效益高的诊断测试的公司来说，这是一个巨大的机会。。

This focus on affordability, combined with the overall growth of the market, creates a favourable environment for both domestic and international players in the cancer diagnostics sector.

这种对负担能力的关注，加上市场的整体增长，为癌症诊断部门的国内和国际参与者创造了有利的环境。

Key Topics Covered:

涵盖的关键主题：

1. India Cancer Diagnostic Tests Market Overview

1、印度癌症诊断测试市场概况

1.1 Current Market Scenario

1.1当前市场情景

1.2 Future Market Opportunities

1.2未来市场机会

2. India Cancer Diagnostic Tests Market Business Models

2、印度癌症诊断测试市场商业模式

2.1 Hospitals

2.1医院

2.2 Private Diagnostic Labs

2.2私人诊断实验室

3. Lung Cancer Diagnosis in India

3、印度肺癌诊断

3.1 Market Overview

3.1市场概况

3.2 Tests Availability & Pricing

3.2测试可用性和定价

4. Prostate Cancer Diagnosis in India

4、印度前列腺癌诊断

4.1 Market Overview

4.2 Tests Availability & Pricing

4.2测试可用性和定价

5. Cervical Cancer Diagnosis in India

5、印度宫颈癌诊断

5.1 Market Overview

5.1市场概况

5.2 Tests Availability & Pricing

5.2测试可用性和定价

6. Breast Cancer Diagnosis in India

6、印度乳腺癌诊断

6.1 Market Overview

6.1市场概述

6.2 Tests Availability & Pricing

6.2测试可用性和定价

7. Oral Cancer Diagnosis in India

7、印度口腔癌诊断

7.1 Market Overview

7.1市场概况

7.2 Tests Availability & Pricing

7.2测试可用性和定价

8. Stomach Cancer Diagnosis in India

8、印度胃癌诊断

8.1 Market Overview

8.1市场概况

8.2 Tests Availability & Pricing

8.2测试可用性和定价

9. Pancreatic Cancer Diagnosis in India

9、印度胰腺癌诊断

9.1 Market Overview

9.1市场概况

9.2 Tests Availability & Pricing

9.2测试可用性和定价

10. Hepatocellular Cancer Diagnosis in India

印度的肝细胞癌诊断

10.1 Market Overview

10.1市场概述

10.2 Tests Availability & Pricing

10.2测试可用性和定价

11. Colorectal Cancer Diagnosis in India

11、印度结直肠癌诊断

11.1 Market Overview

11.1市场概况

11.2 Tests Availability & Pricing

11.2测试可用性和定价

12. Hematological Cancers Diagnosis in India

印度的血液癌症诊断

12.1 Market Overview

12.1市场概况

12.2 Tests Availability & Pricing

12.2测试可用性和定价

13. India Cancer Diagnostic Tests Market Dynamics

13、印度癌症诊断测试市场动态

13.1 Market Drivers & Opportunities

13.1市场驱动因素和机会

13.2 Market Challenges & Restraints

13.2市场挑战和限制

14. Competitive Landscape

Aarthi Scans and Labs

Aarthi扫描和实验室

Apollo Diagnostics (Apollo Health and Lifestyle Limited)

阿波罗诊断公司（阿波罗健康与生活方式有限公司）

DNA Forensics Laboratory

DNA取证实验室

DNA Labs India

DNA实验室印度

Dr. Lal PathLabs

Lal PathLabs博士

Fortis Healthcare Limited

富通医疗保健有限公司

Ganesh Diagnostic

Ganesh诊断

Pathkind Labs

Pathkind实验室

Tata Memorial Center

塔塔纪念中心

Vijaya Diagnostic Center

维贾亚诊断中心

For more information about this report visit https://www.researchandmarkets.com/r/2oddc3

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/2oddc3

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。